Literature DB >> 20053801

Percutaneous vertebroplasty and procedural pain.

A Venmans1, C A Klazen, P N Lohle, W J van Rooij.   

Abstract

BACKGROUND AND
PURPOSE: No consensus exists regarding pain management during PV. In this study, we evaluated the effectiveness of local infiltration anesthesia as the only pain medication.
MATERIALS AND METHODS: From September 2008 to March 2009, 44 consecutive patients (35 women and 9 men; mean age, 74 years) with symptomatic OVCFs were included in the study. Lidocaine was infiltrated to the skin and the periosteum of the pedicle. After PV, patients indicated pain sensation on a VAS. In addition, patients indicated the most painful moment during the procedure: lidocaine infiltration, placing the needles, or cement injection. Finally, patients were asked whether pain medication during the procedure was sufficient. After the procedure the surgeon was asked to judge the expected VAS score of the patient.
RESULTS: Mean VAS score was 5.7 (median, 6; range, 1-10). Seventeen of 44 patients (39%) indicated that lidocaine infiltration was insufficient for procedural pain reduction. The mean VAS score of these patients was 7.3 (range, 5-10). Placing the needles was specified as most painful moment in 29 patients (66%), lidocaine infiltration in 11 (25%), and cement injection in 4 (9%). Surgeons' expectations of patients' VAS scores were a mean of 3.3 (median, 3; range, 1-6).
CONCLUSIONS: For a substantial proportion of patients, local infiltration anesthesia was not sufficient for pain reduction during PV. The severity of pain experienced by the patient is usually not appreciated correctly by the surgeon.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053801      PMCID: PMC7964197          DOI: 10.3174/ajnr.A1942

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

Review 1.  Pain assessment.

Authors:  Mathias Haefeli; Achim Elfering
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

2.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study.

Authors:  M H J Voormolen; W P T M Mali; P N M Lohle; H Fransen; L E H Lampmann; Y van der Graaf; J R Juttmann; X Jansssens; H J J Verhaar
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

4.  Median effective infusion dose (ED50) of alfentanil for monitored anesthesia care of percutaneous vertebroplasty of osteoporotic fractures.

Authors:  Musa Sesay; Patrick Tauzin-Fin; Aude Jeannin; Jean Rodolphe Vignes; Vincent Dousset; Pierre Maurette
Journal:  J Neurosurg Anesthesiol       Date:  2009-04       Impact factor: 3.956

5.  Assisted sedation: a safe and easy method for pain-free percutaneous vertebroplasty.

Authors:  A Della Puppa; C Andreula; M Frass
Journal:  Minerva Anestesiol       Date:  2008-03       Impact factor: 3.051

  5 in total
  4 in total

1.  Percutaneous balloon kyphoplasty with the patient under intravenous analgesia and sedation: a feasibility study.

Authors:  M Mohr; D Pillich; M Kirsch; J U Mueller; S Fleck; N Hosten; S Langner
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

2.  Early percutaneous vertebroplasty helps motorsport professionals to resume competition soon after vertebral fracture.

Authors:  Nicolas Amoretti
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

3.  Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.

Authors:  Ying Wang; Jianxun Mi; Ka Lu; Yanxin Lu; KeWei Wang
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

4.  Preoperative prone position exercises: a simple and novel method to improve tolerance to kyphoplasty for treatment of single level osteoporotic vertebral compression fractures.

Authors:  Guangzhou Li; Hao Liu; Qing Wang; Dejun Zhong
Journal:  BMC Musculoskelet Disord       Date:  2017-11-21       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.